Group One Trading’s Genetic Technologies Ltd. GENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-400
Closed -$2K 8448
2022
Q2
$2K Sell
400
-2,180
-84% -$15.8K ﹤0.01% 7465
2022
Q1
$25K Sell
2,580
-3,360
-57% -$32.6K ﹤0.01% 6624
2021
Q4
$56K Sell
5,940
-7,620
-56% -$97.7K ﹤0.01% 6241
2021
Q3
$210K Buy
13,560
+4,500
+50% +$77.2K ﹤0.01% 5126
2021
Q2
$193K Buy
9,060
+3,580
+65% +$72.2K ﹤0.01% 5287
2021
Q1
$114K Buy
5,480
+920
+20% +$21.1K ﹤0.01% 5545
2020
Q4
$82K Buy
+4,560
New +$75.3K ﹤0.01% 4700

Other funds holding GENE

Group One Trading's GENE Position: Q1 2022 in Review

Group One Trading sold out of Genetic Technologies Ltd. (GENE) in Q1 2022, closing a stake of 2,242 shares — an estimated $21.8K sold.

Group One Trading first reported a position in GENE in Q2 2013 and held it in 10 quarters. The position peaked at $338K in Q2 2021. 12 funds tracked by Wall St. Rank hold GENE as of Q1 2022.

  • Group One Trading reported no remaining Genetic Technologies Ltd. position as of Q1 2022 after selling out during the quarter.
  • Group One Trading sold 2,242 Genetic Technologies Ltd. shares in Q1 2022, an estimated $21.8K.
  • Group One Trading first reported a position in Genetic Technologies Ltd. in Q2 2013 and held it in 10 quarters.
  • Group One Trading's Genetic Technologies Ltd. position peaked at $338K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q1 2022.

Based on Group One Trading's 13F filing for Q1 2022, filed 12 May 2022.